How many insider trades does FilingIQ track for APGE?

FilingIQ tracks 138 Form 4 insider transactions for APGE (Apogee Therapeutics, Inc.), covering filings from Jul 13, 2023 onwards. 18 of those were filed in the last 90 days.

Are APGE insiders net buyers or net sellers?

Across the full Form 4 history for APGE, 7 transactions (5%) were open-market purchases and 106 (77%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does APGE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is APGE in?

Apogee Therapeutics, Inc. (APGE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.81B.

APGE insider trading

NasdaqGM Healthcare

Apogee Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

138

Last 90 days

Buys / sells

5% / 77%

Market cap

$5.81B

About Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Company website: www.apogeetherapeutics.com

APGE insider activity at a glance

FilingIQ has scored 138 insider transactions for APGE since Jul 13, 2023. The most recent filing in our index is dated May 1, 2026.

Across the full history, 7 open-market purchases and 106 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on APGE insider trades is 62.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live APGE trades on FilingIQ Raw filings on SEC EDGAR

Latest APGE Form 4 filings

HENDERSON MICHAEL THOMAS Chief Executive Officer

S Jul 5, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding APGE

PERCEPTIVE ADVISORS LLC

$41.95M · 1.5% of AUM

Avoro Capital Advisors LLC

$37.74M · 0.4% of AUM

Opaleye Management Inc.

$29.31M · 3.9% of AUM

Siren, L.L.C.

$22.23M · 1.3% of AUM

Frequently asked

How many insider trades does FilingIQ track for APGE?: FilingIQ tracks 138 Form 4 insider transactions for APGE (Apogee Therapeutics, Inc.), covering filings from Jul 13, 2023 onwards. 18 of those were filed in the last 90 days.
Are APGE insiders net buyers or net sellers?: Across the full Form 4 history for APGE, 7 transactions (5%) were open-market purchases and 106 (77%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does APGE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is APGE in?: Apogee Therapeutics, Inc. (APGE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.81B.

Methodology & sources

Every APGE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.